Planet 13 Holdings (PLNH) EBIT Margin Growth (1y) (2022 - 2026)

Planet 13 Holdings (PLNH) EBIT Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 304.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -157.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,330.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -650.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 8,630.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1,962.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 111.00
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn -332.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -332.00
Dec 31, 2025 6,425.00
Sep 30, 2025 -16,691.00
Jun 30, 2025 -1,402.00
Mar 31, 2025 -757.00
Dec 31, 2024 -4,257.00
Sep 30, 2024 16,716.00
Jun 30, 2024 216.00
Mar 31, 2024 175.00
Dec 31, 2023 11,640.00
Sep 30, 2023 -16,036.00
Jun 30, 2023 -716.00
Mar 31, 2023 -333.00
Dec 31, 2022 -16,465.00
Sep 30, 2022 389.00
Jun 30, 2022 62,424.00
Mar 31, 2022 -3,034.00